Active — Not RecruitingNot Applicable

Autogenous Bone Block Versus Extended Platelet Rich Fibrin Block for Horizontal Augmentation of Maxillary Ridge With Simultaneous Implant Placement

Egypt20 participantsStarted 2024-05-09

Plain-language summary

The aim of the study is directed to assess the clinical and radiographic outcomes of autogenous bone block versus extended PRF block used for horizontal augmentation of atrophied esthetic area of maxillary ridge associated with simultaneous implant placement.

Who can participate

Age range

18 Years – 45 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Maxillary narrow ridge in the esthetic anterior zone (about 4-5 mm in width). * Bone height allows the insertion of at least 8 mm of implant length without the need for vertical augmentation. * Patient aged 18-45 years old. * The presence of enough amount of keratinized gingiva as well as enough space for prosthesis rehabilitation. * Favorable occlusion without presence of parafunctional habits. * Cooperative patient with high motivation and acceptable oral hygiene. * Patients are medically free from systemic diseases or drugs that absolutely contraindicate implant surgery. * Patients able to comply with the required recall visits. Exclusion Criteria: * Local and / or systemic conditions that may affect passively the clinical procedure or results. * Heavy smokers(\>20 cigarettes/d).(1) * Alcohol or drug abuse. * Patients with parafunctional habits (bruxism and clenching). * Pregnancy. * Uncooperative patients.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

bone width

Timeframe: immediately after augmentation and implant placement (T0), and after 3 months (at time of implant loading) (T3) and after six months from implant loading (T6) (totally, 9 months follow up)

Trial details

NCT IDNCT07424573

SponsorNaira elnagar

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-06-23

View on ClinicalTrials.gov More Extented Platelet Rich Fibrin Block trials

Who can participate

Age range

18 Years – 45 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.